American Academy of Allergy, Asthma & Immunology, Feb. 27-March 2

Adobe Stock
Adobe Stock
Published on

The annual meeting of the American Academy of Allergy, Asthma & Immunology was held from Feb. 27 to March 2 in Philadelphia, drawing clinicians, academicians, allied health professionals, and others interested in allergic and immunologic disease. The theme of the 2026 meeting was Advancing Precision Medicine from Discovery to Patient Care, and highlighted recent advances in the fields of allergy, asthma, and immunology.

AAAAI: UV Filtration in HVAC Units May Benefit Children With Asthma

MONDAY, March 9, 2026 (HealthDay News) -- Ultraviolet filtration in heating, ventilation, and air conditioning is associated with alteration in environmental microbial diversity, which may yield an improvement in asthma severity, according to a study presented at the annual meeting of the American Academy of Allergy, Asthma & Immunology, held from Feb. 27 to March 2 in Philadelphia.

AAAAI: GLP-1 Receptor Agonists Linked to Reduction in Asthma Exacerbation Risk

FRIDAY, March 6, 2026 (HealthDay News) -- Glucagon-like peptide-1 receptor agonist treatment is associated with reduced asthma exacerbation risk among individuals with overweight or obesity, without diabetes, according to a study presented at the annual meeting of the American Academy of Allergy, Asthma & Immunology, held from Feb. 27 to March 2 in Philadelphia.

AAAAI: Omalizumab as Effective as Multifood Oral Immunotherapy for Individuals With Food Allergy

FRIDAY, March 6, 2026 (HealthDay News) -- Individuals with one to three allergenic foods are able to introduce and continue eating allergenic foods at 12 months after multifood oral immunotherapy or omalizumab, according to a study presented at the annual meeting of the American Academy of Allergy, Asthma & Immunology, held from Feb. 27 to March 2 in Philadelphia.

AAAAI: No Increase Seen in Asthma Exacerbations With ICI Use for Melanoma, Renal Cell Carcinoma

THURSDAY, March 5, 2026 (HealthDay News) -- For patients with asthma, receipt of immune checkpoint inhibitor therapy for melanoma or renal cell carcinoma is not associated with an increased risk for exacerbations, according to a study presented at the annual meeting of the American Academy of Allergy, Asthma & Immunology, held from Feb. 27 to March 2 in Philadelphia.

AAAAI: Peanut Allergy Risk Increased in Younger Siblings of Peanut-Consuming Children

THURSDAY, March 5, 2026 (HealthDay News) -- Younger siblings of peanut-consuming children have an increased risk for peanut sensitization and allergy, which can be mitigated by early introduction of peanuts, according to a study presented at the annual meeting of the American Academy of Allergy, Asthma & Immunology, held from Feb. 27 to March 2 in Philadelphia.

Related Stories

No stories found.
Clinical Briefing Report
clinicalbriefingreport.com